News and Announcements
Actinogen Medical Annual General Meeting & Presentation
- Published December 02, 2016 3:34PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
30th November 2016, ASX Announcement
Progress with the development of Xanamem
Since addressing you at the AGM this time last year, Actinogen has made substantial progress towards the initiation of XanADu, our Phase II study of Xanamem in mild Alzheimer’s disease. While we did expect to have initiated patient’s recruitment onto the trial by now, as previously announced, ongoing interaction with the FDA in America has led to some changes in the trial design, that required harmonising the protocol globally. We are particularly pleased with the progress we have made in recent correspondence with the FDA and have every expectation we will receive FDA approval in the near future, and to be able to start dosing patients into the study early in the new year. The trial will take around 2 years to complete, so we can expect top-line results by early 2019.
To view the full announcement, please click on the button below.
To view the full Presentation, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
